Abstract:Obesity contributes to many cancers, including breast cancer and multiple myeloma, two cancers that often colonize the bone marrow (BM). Obesity often causes metabolic disease, but at the cellular level, there is uncertainty regarding how these shifts affect cellular phenotypes. Evidence is building that different types of fuel affect tumor cell metabolism, mitochondrial function, and signaling pathways differently, but tumor cells are also flexible and adapt to less-than ideal metabolic conditions, suggesting that single-pronged attacks on tumor metabolism may not be efficacious enough to be effective clinically. In this review, we describe the newest research at the pre-clinical level on how tumor metabolic pathways and energy sources affect cancer cells, with a special focus on multiple myeloma (MM). We also describe the known forward-feedback loops between bone marrow adipocytes (BMAds) and local tumor cells that support tumor growth. We describe how metabolic targets and transcription factors related to fatty acid (FA) oxidation, FA biosynthesis, glycolysis, oxidative phosphorylation (OXPHOS), and other pathways hold great promise as new vulnerabilities in myeloma cells. Specifically, we describe the importance of the acetyl-CoA synthetase (ACSS) and the acyl-CoA synthetase long chain (ACSL) families, which are both involved in FA metabolism. We also describe new data on the importance of lactate metabolism and lactate transporters in supporting the growth of tumor cells in a hypoxic BM microenvironment. We highlight new data showing the dependency of myeloma cells on the mitochondrial pyruvate carrier (MPC), which transports pyruvate to the mitochondria to fuel the tricarboxylic acid (TCA) cycle and electron transport chain (ETC), boosting OXPHOS. Inhibiting the MPC affects myeloma cell mitochondrial metabolism and growth, and synergizes with proteosome inhibitors in killing myeloma cells. We also describe how metabolic signaling pathways intersect established survival and proliferation pathways; for example, the fatty acid binding proteins (FABPs) affect MYC signaling and support growth, survival, and metabolism of myeloma cells. Our goal is to review the current the field so that novel, metabolic-focused therapeutic interventions and treatments can be imagined, developed and tested to decrease the burden of MM and related cancers.

Relationship Between Adipocytes and Hematological Tumors in the Bone Marrow Microenvironment: a Literature Review

Bone Marrow Adipocyte: an Intimate Partner with Tumor Cells in Bone Metastasis

Bone Marrow Adipocytes, Adipocytokines, and Breast Cancer Cells: Novel Implications in Bone Metastasis of Breast Cancer

Bone marrow adipocytes and lung cancer bone metastasis: unraveling the role of adipokines in the tumor microenvironment

Contribution of adipocytes in the tumor microenvironment to breast cancer metabolism

Bone Marrow Adipocytes: A Critical Player in the Bone Marrow Microenvironment

Distinct Metabolism of Bone Marrow Adipocytes and their Role in Bone Metastasis

Bone Marrow Adipose Tissue

Adipo-oncology: adipocyte-derived factors govern engraftment, survival, and progression of metastatic cancers

The relationship between adipose tissue and bone metabolism

Lipids in the tumor microenvironment: From cancer progression to treatment

Adipocytes and metabolism: Contributions to multiple myeloma

Adipogenic Niches for Melanoma Cell Colonization and Growth in Bone Marrow

Bone marrow adiposity during pathologic bone loss: molecular mechanisms underlying the cellular events

The Fat and the Bad: Mature Adipocytes, Key Actors in Tumor Progression and Resistance

Cancer-associated adipocytes: key players in breast cancer progression

Bone Marrow Adipocytes Promote the Survival of Multiple Myeloma Cells and Up-Regulate Their Chemoresistance

Tumor-associated Adipose Tissue Microenvironment Supports Tumor Progression

Bone Marrow Small Adipocytes in Acute Myeloid Leukemia Correlate with Prognosis

Lipids and adipocytes involvement in tumor progression with a focus on obesity and diet

Metabolic crosstalk between thermogenic adipocyte and cancer cell: Dysfunction and therapeutics